ALGS
Price
$6.07
Change
-$0.38 (-5.89%)
Updated
Nov 13 closing price
Capitalization
36.8M
Intraday BUY SELL Signals
MESO
Price
$14.92
Change
-$0.78 (-4.97%)
Updated
Nov 13 closing price
Capitalization
1.94B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs MESO

Header iconALGS vs MESO Comparison
Open Charts ALGS vs MESOBanner chart's image
Aligos Therapeutics
Price$6.07
Change-$0.38 (-5.89%)
Volume$73.84K
Capitalization36.8M
Mesoblast
Price$14.92
Change-$0.78 (-4.97%)
Volume$207.18K
Capitalization1.94B
ALGS vs MESO Comparison Chart in %
ALGS
Daily Signal:
Gain/Loss:
MESO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALGS vs. MESO commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a StrongBuy and MESO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ALGS: $6.07 vs. MESO: $14.92)
Brand notoriety: ALGS and MESO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 89% vs. MESO: 85%
Market capitalization -- ALGS: $36.8M vs. MESO: $1.94B
ALGS [@Biotechnology] is valued at $36.8M. MESO’s [@Biotechnology] market capitalization is $1.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileMESO’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • MESO’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGS is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 4 TA indicator(s) are bullish while MESO’s TA Score has 3 bullish TA indicator(s).

  • ALGS’s TA Score: 4 bullish, 6 bearish.
  • MESO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than MESO.

Price Growth

ALGS (@Biotechnology) experienced а -14.51% price change this week, while MESO (@Biotechnology) price change was -0.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

MESO is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.94B) has a higher market cap than ALGS($36.8M). MESO YTD gains are higher at: -20.707 vs. ALGS (-84.764). MESO (-73.66M) and ALGS (-75.81M) have comparable annual earnings (EBITDA) . MESO has more cash in the bank: 161M vs. ALGS (123M). ALGS has less debt than MESO: ALGS (6.88M) vs MESO (128M). MESO has higher revenues than ALGS: MESO (17.2M) vs ALGS (3.17M).
ALGSMESOALGS / MESO
Capitalization36.8M1.94B2%
EBITDA-75.81M-73.66M103%
Gain YTD-84.764-20.707409%
P/E RatioN/AN/A-
Revenue3.17M17.2M18%
Total Cash123M161M76%
Total Debt6.88M128M5%
FUNDAMENTALS RATINGS
MESO: Fundamental Ratings
MESO
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSMESO
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 8 days ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
MESO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIDAX19.200.18
+0.95%
JHancock Financial Industries A
DHMYX27.400.11
+0.40%
Diamond Hill Small-Mid Cap Y
CMDYX14.410.05
+0.35%
Columbia Mid Cap Index Inst3
JEGRX18.180.06
+0.33%
Janus Henderson Global Sust Eq R
MLAAX11.20-0.02
-0.18%
NYLI Winslow Large Cap Growth Class A

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with ARWR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-5.96%
ARWR - ALGS
42%
Loosely correlated
-0.68%
BEAM - ALGS
42%
Loosely correlated
-0.96%
RXRX - ALGS
40%
Loosely correlated
-6.88%
DSGN - ALGS
40%
Loosely correlated
-7.23%
XNCR - ALGS
40%
Loosely correlated
-2.78%
More

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+1.09%
QTTB - MESO
51%
Loosely correlated
-3.57%
ALGS - MESO
34%
Loosely correlated
-3.37%
TNGX - MESO
33%
Poorly correlated
-8.47%
AVTX - MESO
32%
Poorly correlated
-0.45%
TRAW - MESO
31%
Poorly correlated
+13.23%
More